Published 2025-01-01
“…
Savak Teymoorian, Jasmin Kaur Harvard Eye Associates, Laguna Hills, CA, USACorrespondence:
Savak Teymoorian, Harvard Eye Associates, 23961 Calle de la Magdalena, Suite 300, Laguna Hills, California, 92653, USA, Tel +1 949-951-2020, Fax +1 949-356-1660, Email steymoorian@harvardeye.comPurpose: To assess real-world efficacy and safety of standalone travoprost intracameral implant (iDose TR) implantation by a US glaucoma surgeon in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).Methods: This non-randomized, retrospective, unmasked, consecutive case series included all cases of standalone iDose TR implantation from a single US glaucoma surgeon since the product’s approval by the US Food and Drug Administration (FDA) in December 2023. …”
Get full text
Article